ClinicalTrials.gg
Not yet recruitingNCT07432464Updated Feb 25, 2026

The Effect of Nomophobia Levels on Anxiety and Academic Self-Efficacy in Students With Text Neck

An observational study in Text Neck, Nomofobia and Academic Self-sufficiency, sponsored by Istanbul Arel University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-25.

Sponsored by Istanbul Arel University · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
396
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The aim of this study is to examine the effect of nomophobia levels on anxiety and academic self-efficacy in university students with text neck. In this regard, the comprehensive assessment aims to reveal the relationships between nomophobia, anxiety and academic self-efficacy by considering the physical and psychosocial variables associated with text neck together. Furthermore, the study highlights that approaches to text neck rehabilitation in the existing literature are mostly limited to the physical dimension, while psychosocial components are insufficiently addressed. It therefore aims to identify knowledge gaps and research needs in this area.

02

Conditions studied

  • Text Neck
  • Nomofobia
  • Academic Self-sufficiency
03

In context

Lead sponsor

Istanbul Arel University is the lead sponsor of 44 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals aged 18-35 who are in education

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Being aged between 18 and 35

      • Being a university student
      • Using a smartphone for at least 3 hours per day, as assessed by the Text Neck evaluation

Exclusion criteria

Exclusion Criteria:

    • Individuals under the age of 18

      • Individuals who are not enrolled in any university
      • Individuals who do not agree to participate as volunteers
      • Individuals who are not eligible for Text Neck assessment or do not experience pain
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
396 participants (estimated)
Target follow-up
4 Months
Patient registry
Yes

Groups and cohorts

  • The Effect of Nomophobia Levels in Students with Text Neck on Anxiety and Academic Self-Efficacy

    Other: online survey application

Interventions

  • Otheronline survey application

    This study is one of the limited number of investigations that simultaneously and holistically examines the effects of text neck on anxiety and academic self-efficacy, focusing on the level of nomophobia among university students with text neck. Unlike most text neck studies in the literature, which predominantly focus on physical symptoms, this research considers psychosocial variables as an integral part of the rehabilitation process. In this respect, the study sheds light on the multidimensional effects of text neck on not only postural but also academic and psychological functioning, thereby making a unique contribution to the field.

06

What researchers measure

Primary outcomes

  1. The Effect of Nomophobia Levels on Text Neck and Academic Self-Efficacy

    The survey will remain open for 2 months. Participants will be contacted via social media, WhatsApp messages, and advertisements.

    Time frame: up to 12 weeks

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2026; primary completion for Feb 2026, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2026
First posted
Feb 25, 2026
StartEst.
Feb 15, 2026
Primary completionEst.
Feb 28, 2026
CompletionEst.
Mar 15, 2026
Last update
Feb 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07432464
Lead sponsor
Istanbul Arel University
Responsible party
Sponsor
First posted
Feb 25, 2026
Start date
Feb 15, 2026 (estimated)
Primary completion
Feb 28, 2026 (estimated)
Completion
Mar 15, 2026 (estimated)
Last update
Feb 25, 2026

Study contacts

ilknur ATKIN, Lecturer
Contact
ilknuratkin@gmail.com
5454586926

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion